International Research Journal of Ayurveda & Yoga
2023
P. Yadav
Background -People's lifestyles have become very mechanical in the modern day. Everyone is in a rat race to meet their goals, which causes stress. The repercussions of this stress on a person's physical and mental health are further. The healthy development of emotional attitudes and personality that coexist peacefully with the entire society or community is what is meant by mental health....
PLoS One
2023
Mark S Nestor, Alec Lawson, Daniel Fischer
Frontline Healthcare provider (HCP) burnout has dramatically increased due to the COVID 19 pandemic. Hospitals are supporting wellness programs and techniques to reduce burnout including the Transcendental Meditation (TM) technique. This study evaluated the use of TM on HCP symptoms of stress, burnout and wellness. A total of 65 HCPs at three South Florida hospitals were recruited and...
2023
Shannon B. Underwood
Background: Self-compassion has received increased attention as a process of change inevidence-based psychotherapies, owing to its relation with numerous positive health outcomes. Though several practices have been shown to increase self-compassion, our aim here is to evaluate the utility of one particular practice, namely loving-kindness or metta meditation (LKM). Despite evidence supporting...
International Journal of Research and Innovation in Applied Science
2023
Ravindra B. Malabadi, Kiran P. Kolkar, Raju K. Chalannavar et al.
4 citations
This review paper highlights about Medical Cannabis sativa (Marijuana or drug type) containing psychoactive molecule, Δ9-Tetrahydrocannabinol (Δ9-THC) as a part of educational awareness programme in India. Cannabis sativa and Cannabis indica were originally a native of India growing as a wild notorious noxious weed in the Indian Himalayan region. Marijuana (Charas, Ganja and Bhang in India) is...
Molecular Psychiatry
2023
Gilly Wolf, Sandeep Singh, Karin Blakolmer et al.
Schizophrenia is a widespread psychiatric disorder that affects 0.5-1.0% of the world's population and induces significant, long-term disability that exacts high personal and societal cost. Negative symptoms, which respond poorly to available antipsychotic drugs, are the primary cause of this disability. Association of negative symptoms with cortical atrophy and cell loss is widely reported....
Current reviews in clinical and experimental pharmacology
2023
Rabeet Tariq
5 citations
Psychedelics might be the oldest psychoactive agents known to be used for inducing religious or mystical experiences. Their strong psychoactive effect was discovered accidentally in 1943 after the synthesis of Lysergic acid diethylamide (LSD) in 1937. These drugs became a mainstream area of research following the synthesis of LSD; however, several political and social factors led to their ban...
Transformation and the History of Philosophy
2023
Adam Bradley
Since their introduction to mainstream culture and medicine in the middle of the 20th century, psychedelic substances have been investigated for their therapeutic potential. Research on psychedelic therapy, or the use of moderate-to-large doses of psychedelics in the context of therapy, indicates that psychedelics have great potential to treat disorders such as depression, addiction, and...
Pharmacotherapy in Psychiatry and Neurology
2023
Jakub Schimmelpfennig, Kamila Jankowiak-Siuda
AMA Schimmelpfennig J, Jankowiak-Siuda K. Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):115-130. doi:10.5114/fpn.2023.131979. APA Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023). Therapeutic potential of N,N-dimethyltryptamine in...
Drug Science, Policy and Law
2023
Adriana D’arienzo, Giorgio Samorini
In recent years, the historical record of psychedelic therapy in Europe and the Americas has undergone considerable revision. In this article, we contribute to this re-interpretation by sharing documentation relating to psychedelic therapy carried out in Italy during the period 1927–1966. Our library research has uncovered one hundred publications, documenting at least 60 clinical studies in...
Open Journal of Medical Psychology
2023
John R. Rossiter
1 citation
Objective: Psychedelic drug therapy is banned in all countries of the world except Australia, where the government regulatory watchdog, the Therapeutic Goods Administration, is planning to allow approved psychiatrists, as of July 1, 2023, to prescribe psilocybin to treat depression and MDMA to treat post-traumatic stress disorder, a move precipitated by the U.S. Food and Drug Administration’s...